Sky Century Investment (SKYI) Cash from Investing Activities (2024 - 2025)

Sky Century Investment (SKYI) reported Cash from Investing Activities of -$18000.0 for Q4 2025, down 3.45% quarter-over-quarter from -$17400.0 in Q3 2025.

Sky Century Investment (SKYI) Cash from Investing Activities (2024 - 2025) Analysis & Trends

Sky Century Investment (SKYI) has 2 years of Cash from Investing Activities data on file, last reported at -$18000.0 in Q4 2025.

  • Cash from Investing Activities for Q4 2025 came in at -$18000.0, changed N/A year-over-year; the trailing twelve-month figure through Feb 2026 was -$94600.0 (down 114.8% YoY), and the FY2025 annual result was -$92140.0, down 223.3% from the prior year.
  • Cash from Investing Activities retreated to -$18000.0 in Q4 2025 per SKYI's latest filing, from -$17400.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$15540.0 in Q1 2025 and troughed at -$59200.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -2.08 Bn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 25.99 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -15.45 Mn
10 Sky Century Investment - - 31,666.00 -

Historic Data

Download Data
DateValue
Nov 30, 2025 -18,000.00
Nov 30, 2025 -18,000.00
Aug 31, 2025 -17,400.00
Aug 31, 2025 -17,400.00
May 31, 2025 -59,200.00
May 31, 2025 -59,200.00
Feb 28, 2025 -15,540.00
Feb 28, 2025 -15,540.00
Aug 31, 2024 -28,500.00
Aug 31, 2024 -28,500.00